Ticker

No recent analyst price targets found for RBGPF.

Latest News for RBGPF

Reckitt Benckiser: Core Brands Remain Undervalued Despite Mead Johnson Litigation Risk

I rate Reckitt Benckiser a buy with a 12–24 month horizon and medium confidence, citing a 21% discount to peer multiples despite litigation overhang. Core Reckitt delivers high-margin, volume-led growth, with FY2025 organic growth of +5.2% and a 26.7% adjusted operating margin, supporting quality business status. Mead Johnson litigation risk remains the key discount driver; recent favorable legal outcomes improve…

Seeking Alpha • Aug 7, 2026
Reckitt Benckiser Group H1 Earnings Call Highlights

Reckitt Benckiser Group LON: RKT reported accelerating sales growth in the second quarter of 2026, supported by innovation, emerging-market demand and a return to growth in North America, while maintaining its full-year outlook despite commodity and supply-chain volatility.

MarketBeat • Jul 29, 2026
Reckitt launches £500m buyback as quarterly sales accelerate

Reckitt Benckiser Group PLC (LSE:RKT) has launched a new £500 million share buyback after second-quarter sales accelerated across all regions and product categories. The maker of consumer products brands ranging from Dettol to Durex said like-for-like net revenue rose 4.7% in the second quarter, lifting first-half growth to 2.6%.

Proactive Investors • Jul 29, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for RBGPF.

No Senate trades found for RBGPF.

No House trades found for RBGPF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top